ScanSource (NASDAQ:SCSC) posts better-than-expected sales in Q3 2026, guides for strong full-year sales

ScanSource reported Q3 2026 revenue of $962.3M, beating estimates by 11.7% but missing EPS and EBITDA targets. The company guided full-year EBITDA to $180M, above consensus. Operating margin and free cash flow declined year-over-year.

Original reporting
Published Nov 5, 2026, 1:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 2:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ScanSource (NASDAQ:SCSC) posts better-than-expected sales in Q3 2026, guides for strong full-year sales — source image
Decision brief

The 30-second read

$SCSCNeutralHigh
01

Why it matters

Revenue beat and raised full‑year EBITDA guidance suggest growth momentum, but EPS and EBITDA misses plus negative free cash flow raise profitability concerns.

02

Market read

The earnings release provides fresh data that can influence short‑term price action and sector sentiment for distribution software stocks.

03

What to watch

Free cash flow turned negative, indicating cash‑burn concerns despite top‑line growth.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

ScanSource (NASDAQ:SCSC) is a provider of technology distribution and supply‑chain solutions. The company released its Q3 2026 results.

Company-level read

Ticker impact

$SCSCNeutralHigh confidence
Context

ScanSource reported Q3 revenue of $962.3M beating estimates and provided full-year EBITDA guidance above consensus.

Expected impact

likely modest upside as market prices in the revenue beat and raised guidance, but EPS miss may limit gains

Evidence & confidence

Revenue beat and upgraded guidance are fresh, material data that can move the stock; EPS miss tempers enthusiasm.

Market effects

Positive signal for B2B distribution and supply‑chain software providers as revenue growth exceeds expectations.

Limited to U.S. small‑cap technology distribution sector.

Low; impact confined to investors tracking niche distribution software stocks.

Counterpoint

EPS and EBITDA misses could signal margin pressure; investors may short on deteriorating profitability.

Key entities

  • ScanSource

    Technology distribution and supply‑chain solutions provider.

Related articles

$SCSCHighAI 8/10

ScanSource Q1 Sales Rise 30.1%; Adjusted Diluted EPS Is $0.86

ScanSource reported Q1 fiscal 2027 net sales of $962.3M, up 30.1% YoY, with adjusted diluted EPS of $0.86. Gross profit rose 8.8% to $116.9M, but operating income fell 52.2%. The company raised its fiscal 2027 outlook following the MicroAge acquisition, expecting net sales of $3.8B-$4.0B and adjusted EBITDA of $175M-$185M.

$SCSCHigh

SCANSOURCE REPORTS FIRST QUARTER RESULTS

SCANSOURCE, INC. (SCSC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Steve Jones Mary M. Gentry Senior EVP, Chief Financial Officer SVP, Finance and Treasurer ScanSource, Inc. ScanSource, Inc. (864) 286-4302 (864) 286-4892 SCANSOURCE REPORTS FIRST QUARTER RESULTS Strong Demand Drives Net Sales and Gross

$SCSCMedAI 8/10

ScanSource (SCSC) Bets $220M On A Bigger IT Footprint

ScanSource (SCSC) completed a $220.5M cash acquisition of MicroAge. SCSC's Q4 saw 17.3% sales growth and 43% EPS increase. MicroAge is expected to boost margins and free cash flow. SCSC used credit facilities for the deal, doubling its debt. Q4 gross margin slipped to 12.6%. Fiscal 2027 guidance excludes MicroAge. Hedge fund ownership rose, and the stock trades at a forward P/E of 11.95.